Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis

Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis

ObjectivesStandard 6-week and hypofractionated 3-week courses of adjuvant radiation therapy (RT) are both options for older patients with glioblastoma (GBM), but deciding the optimal regimen can be challenging. This analysis explores clinical factors associated with selection of RT course, completio...

Full description

Bibliographic Details
Main Authors:	Jessica W. Lee, John P. Kirkpatrick, Frances McSherry, James E. Herndon, Eric S. Lipp, Annick Desjardins, Dina M. Randazzo, Henry S. Friedman, David M. Ashley, Katherine B. Peters, Margaret O. Johnson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	glioblastoma frail elderly aged radiotherapy radiation dose hypofractionation radiation oncology
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.631618/full

Similar Items

Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients – early results of a phase II trial.
by: Scott eFloyd, et al.
Published: (2012-10-01)

Treatment options and outcomes for glioblastoma in the elderly patient
by: Arvold ND, et al.
Published: (2014-02-01)

A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer
by: Shivaprasad Deshmukh, et al.
Published: (2016-07-01)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
by: Matthew Richardson, et al.
Published: (2018-05-01)

Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
by: Makoto Ohno, et al.
Published: (2019-11-01)

Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes
by: Darius Kalasauskas, et al.
Published: (2020-03-01)

Three-Times Daily Ultrafractionated Radiation Therapy, A Novel and Promising Regimen for Glioblastoma Patients
by: Patrick Beauchesne
Published: (2013-09-01)

HYPOFRACTIONATED RADIOTHERAPY PART OF MULTIMODALITY TREATMENT IN MULTICENTRIC GLIOBLASTOMA MULTIFORME: A CASE REPORT
by: Vanessa MOLDOVEANU, et al.
Published: (2018-12-01)

Radiation Boost After Adjuvant Whole Breast Radiotherapy: Does Evidence Support Practice for Close Margin and Altered Fractionation?
by: Stephanie Gulstene, et al.
Published: (2020-06-01)

Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
by: Jane-Chloe Trone, et al.
Published: (2020-06-01)

Current status and recent advances in reirradiation of glioblastoma
by: Giuseppe Minniti, et al.
Published: (2021-02-01)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
by: Guixiang Liao, et al.
Published: (2019-10-01)

UNCONVENTIONAL FRACTIONATION RADIOTHERAPY REGIMENS IN TREATMENT OF INOPERABLE LUNG CANCER
by: D. V. Gogolin, et al.
Published: (2019-09-01)

Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study
by: Benjamin Stegen, et al.
Published: (2020-01-01)

Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients
by: Byung Min Lee, et al.
Published: (2020-02-01)

In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
by: Samira Borhani, et al.
Published: (2017-05-01)

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
by: Osama Mohamad, et al.
Published: (2018-07-01)

Adaptive hypofractionated radiotherapy combined with chemotherapy and anti-angiogenic therapy for residual and recurrent glioblastoma after surgery: A case report
by: Yuchao Ma, et al.
Published: (2020-01-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
by: Georges Noël, et al.
Published: (2013-09-01)

A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients
by: Kartick Rastogi, et al.
Published: (2018-01-01)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
by: Geoffrey Martinage, et al.
Published: (2019-03-01)

INFLUENCE OF PERITUMORAL EDEMA ON THE OUTCOME OF RADIOTHERAPY OF SUPRATENTORIAL NONCYSTIC GLIOBLASTOMA MULTIFORME
by: Ivan Stefanović, et al.
Published: (2011-09-01)

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a “real-life” report
by: J. Biau, et al.
Published: (2017-12-01)

Accelerated Hypofractionated Whole Breast Radiotherapy for Early Breast Cancer; A Randomized Phase III Clinical Trial
by: Sare Hosseini, et al.
Published: (2020-05-01)

A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
by: Amit Maity, et al.
Published: (2021-01-01)

Radiotherapy of glioblastoma 15 years after the landmark Stupp’s trial: more controversies than standards?
by: Kazda Tomas, et al.
Published: (2018-06-01)

Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China
by: Lu Xie, et al.
Published: (2021-03-01)

ACCELERATED REGIMENS OF ADJUVANT RADIOTHERAPY IN THE TREATMENT OF BREAST CANCER
by: G. V. Afonin, et al.
Published: (2017-09-01)

Influence of Radiation Dose to Reconstructed Breast Following Mastectomy on Complication in Breast Cancer Patients Undergoing Two-Stage Prosthetic Breast Reconstruction
by: Jee Suk Chang, et al.
Published: (2019-04-01)

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
by: Xanthene Miles, et al.
Published: (2021-07-01)

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
by: Carlo Greco
Published: (2013-09-01)

Hemostatic radiotherapy
by: Aastha Shah, et al.
Published: (2021-01-01)

Combined modality approaches in the management of adult glioblastoma
by: Haider A Shirazi, et al.
Published: (2011-10-01)

Radiation Dose‐Enhancement Is a Potent Radiotherapeutic Effect of Rare‐Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma
by: Anne‐Laure Bulin, et al.
Published: (2020-10-01)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
by: Li D, et al.
Published: (2021-02-01)

Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy
by: Taoran Li, et al.
Published: (2018-03-01)

Current status and recent advances in resection cavity irradiation of brain metastases
by: Giuseppe Minniti, et al.
Published: (2021-04-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)